New Zealand markets closed

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
355.60-17.05 (-4.58%)
As of 11:53AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close372.65
Bid356.60 x 1200
Ask356.90 x 1200
Day's range352.57 - 370.80
52-week range58.81 - 464.00
Avg. volume4,051,504
Market cap86.239B
Beta (5Y monthly)N/A
PE ratio (TTM)19.50
EPS (TTM)18.24
Earnings date09 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est334.31
  • Motley Fool

    Why COVID Vaccine Stocks BioNTech, Moderna, and Novavax Are Sliding While Ocugen Is Rising

    Investors are nervous about a Food and Drug Administration advisory panel meeting and optimistic about a World Health Organization decision.

  • Motley Fool

    Why Moderna and BioNTech Topped the Market Today

    Shares of coronavirus stocks Moderna (NASDAQ: MRNA) and BioNTech (NASDAQ: BNTX) rose on Thursday by 1.4% and 4.9%, respectively, in contrast to the stock market's dip on the day. This followed news that the two companies had their coronavirus vaccines fully approved by a national regulator. On Thursday morning, it switched on the green light for both Moderna's mRNA-1273 (brand-named SpikeVax) and Comirnaty from BioNTech and its development partner Pfizer (NYSE: PFE).

  • Zacks

    Pfizer, Moderna Support COVID Vaccine Booster Before FDA Meet

    Amid rising coronavirus cases, PFE and MRNA are trying to make booster doses of their COVID-19 vaccine available for US citizens. An FDA meeting is scheduled tomorrow to discuss Comirnaty's booster dose.